Phone: (800) 411-7999
CHCWM – Cancer & Hematology Centers of West Michigan

Clinical Trial Type: Lung

C4161001 (Pfizer)

Phase 1/2a Dose Escalation, Finding and Expansion Study Evaluating Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-Tumor Activity of PF-07104091 as a Single Agent and in Combination Therapy.

C4391001 ( Pfizer)

A Phase 1/1B Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti-Tumor Activity of PF-07220060 as a Single Agent and As Part of Combination Therapy In Participants With Advanced Solid Tumors.

Helsinn (ANAM)

A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in adult patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Principal Investigator: Dr. Yuanbin Chen For more information on this trial, read its profile on clinicaltrials.gov here.

Sanofi (CARMEN-LC03)

Randomized, Open Label Phase 3 study of SAR408701 versus Docetaxel in Previously Treated metastatic non-squamous Non-Small Cell Lung Cancer patients with CEACAM5 positive tumors Principal Investigator: Dr. Eric Santos For more information on this trial, read its profile on clinicaltrials.gov here.